CompletedNCT03448016
[C-11]NOP-1A and Addiction
This study is completed in the United States. It focuses on Addiction.
In United StatesAddictionDrugA study involving a medication or substance.From 18 Years to 55 Years
Study directory
Back to overviewMental health studies with practical context.
Compare studies and check their requirements with the research team.
CompletedNCT03746366
[C-11]PiB PET Imaging in Alcohol Use Disorders
This study is completed in the United States. It focuses on Addiction.
In United StatesAddictionDrugFrom 40 Years to 65 Years
TerminatedNCT05551195
Digital Therapeutic for depression
This study was terminated in the United States. It is testing digital Therapeutic for depression.
In United StatesDepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 45 Years
CompletedNCT03888391
12 Month Open Extension of TNS for ADHD.
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesADHDDeviceFrom 8 Years to 13 Years
CompletedNCT00223496
12- Week Open Label Treatment of Refractory Depression in bipolarity
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesBipolarity, DepressionDrugFrom 18 Years to 75 Years
CompletedNCT00583440
12-step Facilitation for the Dually Diagnosed
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesMental healthBehavioralOver 18 Years
TerminatedNCT03110575
12-Week Extension Study of TNX-102 SL in PTSD Patients
This study was terminated in the United States. It is testing TNX-102 SL for PTSD.
In United StatesPTSDDrugFrom 18 Years to 75 Years
CompletedNCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesBipolarity, DepressionDrugFrom 18 Years to 65 Years
CompletedNCT01157351
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
TerminatedNCT02389712
16-week Comparative Effectiveness study of Lamotrigine vs. Fluoxetine for Depression in bipolarity
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesBipolarity, DepressionDrugFrom 18 Years to 65 Years
CompletedNCT06880328
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in people with Schizophrenia
This study is completed in the United States. It focuses on schizophrenia.
In United StatesSchizophreniaBehavioralFrom 18 Years to 50 Years
CompletedNCT03902613
18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolarity
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesBipolarity, DepressionDrugFrom 18 Years to 50 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.